ClinicalTrials.Veeva

Menu
G

Global Medical Institutes, LLC | Princeton Medical Institute

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SPN-812
Viloxazine
ABBV-8E12
Bapineuzumab
PCN-101
AF87908
PRC-063
AL002
LY3303560
SUVN-502

Parent organization

This site is a part of Global Medical Institutes, LLC

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 37 total trials

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (INVOKE-2)

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disea...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AL002

The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheime...

Active, not recruiting
Alzheimer Disease
Cognitive Dysfunction
Drug: JNJ-63733657
Drug: Placebo

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Enrolling
Treatment Resistant Depression
Drug: Psilocybin

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants...

Enrolling
Alzheimer Disease, Early Onset
Other: Placebo
Drug: BMS-986446

Trial sponsors

AbbVie logo
Allergan logo
Bristol-Myers Squibb (BMS) logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Lundbeck logo
Supernus Pharmaceuticals logo
A
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems